Biocause Pharma(000627)
Search documents
天茂实业集团股份有限公司股票可能被终止上市的第六次风险提示公告
Shang Hai Zheng Quan Bao· 2025-08-18 22:12
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:000627 证券简称:*ST天茂公告编号:2025-040 天茂实业集团股份有限公司 股票可能被终止上市的第六次风险提示公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述或者重大遗 漏。 特别提示: 1、天茂实业集团股份有限公司(以下简称"公司")于2025年7月7日披露了《关于股票交易被实施退市 风险警示暨停复牌安排的公告》(公告编号:2025-022),公司无法在法定期限内披露2024年年度报告 和2025年第一季度报告,公司股票已自2025年5月6日开市起停牌,公司在股票停牌的两个月内仍未能披 露2024年年度报告和2025年第一季度报告,公司股票于2025年7月8日复牌并被实施退市风险警示。 2、根据《深圳证券交易所股票上市规则》第 9.4.18 条规定,若公司在股票交易被实施退市风险警示之 日起的两个月内仍未披露过半数董事保证真实、准确、完整的 2024 年年度报告,深圳证券交易所将决 定终止公司股票上市交易。 3、根据《深圳证券交易所股票上市规则》第 9.4.10 条规定,公司股票交易被实施退市风险警示 ...
*ST天茂(000627) - 公司股票可能被终止上市的第六次风险提示公告
2025-08-18 11:04
证券代码:000627 证券简称:*ST天茂 公告编号:2025-040 天茂实业集团股份有限公司 股票可能被终止上市的第六次风险提示公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏。 特别提示: 1、天茂实业集团股份有限公司(以下简称"公司")于 2025 年 7 月 7 日披露了《关于股 票交易被实施退市风险警示暨停复牌安排的公告》(公告编号:2025-022),公司无法在法定 期限内披露 2024 年年度报告和 2025 年第一季度报告,公司股票已自 2025 年 5 月 6 日开市起 停牌,公司在股票停牌的两个月内仍未能披露 2024 年年度报告和 2025 年第一季度报告,公司 股票于 2025 年 7 月 8 日复牌并被实施退市风险警示。 一、公司股票可能被终止上市的原因 公司无法在法定期限内披露 2024 年年度报告和 2025 年第一季度报告,公司股票已自 2025 年 5 月 6 日开市起停牌,公司在股票停牌的两个月内仍未能披露 2024 年年度报告和 2025 年第 一季度报告,公司股票于 2025 年 7 月 8 日复牌并被实施退市风险警 ...
每经热评丨*ST天茂计划主动退市 财报难产投资者如何理性决策?
Mei Ri Jing Ji Xin Wen· 2025-08-17 13:13
Core Viewpoint - The company *ST Tianmao plans to voluntarily delist from the Shenzhen Stock Exchange due to significant uncertainties in its business restructuring, which may have a major impact on the company and its shareholders [1][2] Group 1: Company Actions and Financial Situation - The company announced a cash option for shareholders at a price of 1.6 yuan per share, with an estimated total cost not exceeding 26.07 billion yuan to acquire up to approximately 1.629 billion shares, representing about 33% of the total share capital [1] - The company has been under delisting risk warning since July 8 due to failure to disclose its 2024 annual report and the first quarter report for 2025 within the stipulated time [1][2] - The stock price has significantly declined from over 3 yuan to as low as 1.35 yuan, currently standing at 1.58 yuan as of August 13 [2] Group 2: Investor Decision-Making - Investors face three scenarios for decision-making: significant losses reported, normal operations of the main subsidiary despite losses, or severe losses necessitating drastic measures like delisting [3] - The lack of timely financial reports has severely limited investors' ability to make rational decisions [3][4] Group 3: Risks and Concerns - There is a concern that the company's financial difficulties may lead to a situation where the actual controller acquires shares at a low cost due to the forced selling of shares by investors facing delisting risks [4] - The total assets of Tianmao Group exceed 280 billion yuan, with financial investments amounting to 122.9 billion yuan, indicating that slight changes in discount rates could lead to significant value fluctuations [4] - The planned acquisition price implies a total valuation of only 7.8 billion yuan, raising questions about the fairness of the transaction [4]
*ST天茂信披违规引连锁反应:立案调查、股价震荡及终止上市
2 1 Shi Ji Jing Ji Bao Dao· 2025-08-14 13:29
Core Viewpoint - *ST Tianmao has faced a series of challenges since 2025, including delayed annual reports, stock price drops, and plans to voluntarily delist, raising concerns about investor rights and company transparency [1][2][4]. Group 1: Disclosure Issues - On April 29, 2025, *ST Tianmao announced it could not release its 2024 annual report and Q1 2025 report on time, citing the need for further information [2]. - The stock price fell to 3.04 yuan per share, marking the largest single-day drop in three months, reflecting investor concerns over the company's disclosure practices [2]. Group 2: Financial Performance and Liquidity Concerns - The company is primarily reliant on its subsidiary, Guohua Life, which is facing significant operational pressures, with a projected loss of 500 million to 750 million yuan for the full year of 2024 [3]. - Guohua Life reported a high surrender payment of 20.6 billion yuan in 2023, with compensation expenses surging to 21.822 billion yuan in the first three quarters of 2024, indicating increasing liquidity risks [3]. Group 3: Delisting Plans - On August 14, 2025, *ST Tianmao announced plans to voluntarily withdraw its A-shares from the Shenzhen Stock Exchange due to significant uncertainties affecting the company [4]. - A shareholder meeting is scheduled for August 25, 2025, to discuss the delisting proposal, with stock trading suspended from August 14, 2025 [4].
*ST天茂计划主动退市 财报难产投资者如何理性决策?
Mei Ri Jing Ji Xin Wen· 2025-08-14 08:05
Core Viewpoint - Tianmao Group is facing delisting risks due to failure to disclose its 2024 annual report and Q1 2025 report on time, leading to a choice of voluntary delisting to protect investors [1][4] Group 1: Company Financial Situation - The company announced a projected loss of 500 million to 750 million yuan for 2024, which caused a significant drop in stock price, although it only fell by 5.54% on the announcement day [2] - The stock price has continued to decline, reaching as low as 1.35 yuan, and was at 1.58 yuan as of August 13 [1] - The actual controller has taken responsibility, offering investors a cash option to mitigate losses, with a buyback price set at 1.6 yuan per share, potentially costing up to 2.607 billion yuan [4] Group 2: Investor Decision-Making - Investors face three scenarios: continued holding due to potential recovery, accepting cash options due to severe losses, or uncertainty leading to forced selling at low prices [2][3] - The lack of timely financial disclosures has severely impacted investors' ability to make informed decisions, leading to fears regarding delisting and stock performance [3] Group 3: Market Implications - The company’s total assets exceed 280 billion yuan, with financial investments amounting to 122.9 billion yuan, indicating that slight changes in discount rates could lead to significant financial impacts [3] - The valuation of Tianmao Group is concerning, with a net asset value of 21.8 billion yuan, while the buyback plan suggests a total valuation of only 7.8 billion yuan, raising questions about the fairness of the transaction [5]
A股市场破净股一览:305只个股股价跌破每股净资产
Di Yi Cai Jing· 2025-08-14 07:49
Group 1 - As of August 14, a total of 305 A-share stocks have their prices falling below the net asset value per share, excluding negative data [1] - The companies with the lowest price-to-net asset ratios include Meikailong at 0.272 times, Jindi Group at 0.299 times, and *ST Tianmao at 0.357 times [1]
每经热评︱*ST天茂计划主动退市 财报难产投资者如何理性决策?
Mei Ri Jing Ji Xin Wen· 2025-08-14 07:28
每经评论员 杜恒峰 缺少财报方面的关键信息,投资者便难以作出最理性的决策。天茂集团是一家控股公司,旗下国华人寿 才是其经营主体。目前,投资者可基于三种情形进行决策:一是1月21日公司公告2024年预亏5亿元~7.5 亿元,尽管亏损额较大,但当天股价仅下跌5.54%,次日则出现涨停,此后年报难产使得相关数据的可 信度大打折扣。二是国华人寿业绩亏损较大,但整体运营正常(8月5日的公告称"公司正常经营"),考 虑到保险公司的长久期负债对利率高度敏感,这些亏损可能只是账面情况而非现金流亏损,一旦利率企 稳,业绩或将反弹。三是国华人寿业绩亏损过于巨大,需要通过天茂集团退市这样的特殊措施来挽救局 面。笔者认为,如果是情形一和情形二,继续持股似乎相对合理一些;若是情形三,则行使现金选择权 相对有利。 当然,对投资者而言,还会存在另一种假设:年报难产导致股价跌至低位,退市风险倒逼投资者卖出手 中的低价筹码,实控人借此以最低成本获得上市公司尽可能多的股权,年报实际上被异化成达成这一目 的的工具。无论属于上述哪种情形,投资者的知情权都受到了极大损害,未来在对退市决议进行投票 时,他们内心更多的是对未知信息和退市风险的恐惧,而无法 ...
000627,拟主动退市!今起停牌!
Zhong Guo Jing Ji Wang· 2025-08-14 06:56
登录新浪财经APP 搜索【信披】查看更多考评等级 8月13日晚间,*ST天茂(000627)公告,公司拟以股东会决议方式主动撤回A股股票在深交所的上市交易,并在股票终止上市后申请转入全国 中小企业股份转让系统有限责任公司代为管理的退市板块转让。 公司将于8月25日召开2025年第一次临时股东会,审议公司以股东会决议方式主动终止上市相关议案。本次股东会股权登记日为8月13日。根据 相关规则,公司股票自股东会股权登记日的次一交易日,即2025年8月14日开市起停牌。 *ST天茂此前公告,由于公司拟进行业务结构调整,面临重大不确定性,可能对公司造成重大影响。为保护中小股东利益,根据相关规定,经 公司董事会审议通过,公司拟以股东会决议方式主动撤回A股股票在深交所的上市交易,并在股票终止上市后申请转入全国中小企业股份转让 系统有限责任公司代为管理的退市板块转让。 除了拟主动退市外,公司目前也处于退市危机中。8月12日,公司发布了《股票可能被终止上市的第五次风险提示公告》。公告显示,公司无 法在法定期限内披露2024年年度报告和2025年第一季度报告,公司股票已自2025年5月6日开市起停牌,公司在股票停牌的两个月内仍未 ...
A股大消息!罕见主动退市,影响11万股东!大抉择来了
中国基金报· 2025-08-14 06:53
Core Viewpoint - The decision of whether *ST Tianmao will voluntarily delist is crucially dependent on the votes of minority shareholders holding less than 5% of the shares, as they will play a key role in the upcoming shareholder meeting [5][8]. Group 1: Shareholder Meeting and Delisting Proposal - *ST Tianmao will hold its first extraordinary general meeting of 2025 on August 25 to discuss the proposal for voluntary delisting [3][10]. - The stock will be suspended from trading starting August 14, 2025, following the registration date for shareholders [3][10]. - The proposal requires approval from two-thirds of the voting rights of all shareholders and two-thirds of the voting rights of minority shareholders [6][10]. Group 2: Current Financial Situation and Risks - The company has not released its 2024 annual report, which poses a risk of being forced to delist [12][13]. - If the company fails to disclose the required annual report within two months after being warned, it will face mandatory delisting [14]. - The stock has been under risk warning since July 8, 2025, due to the failure to disclose financial reports [12][14]. Group 3: Shareholder Dynamics and Cash Option - As of July 18, 2025, *ST Tianmao had approximately 111,900 shareholders, with a significant portion being minority shareholders [9][8]. - A cash option is being offered to all shareholders, including dissenting ones, at a price of 1.60 yuan per share, which provides a potential exit strategy for investors [10][16]. - Following the announcement of the voluntary delisting, the stock price increased nearly 9%, closing at 1.58 yuan per share on August 13, 2025, just below the cash option price [10][16].
又一家上市公司拟主动退市 此前因年报逾期“披星戴帽”
Jin Rong Shi Bao· 2025-08-14 02:28
公告显示,截至8月8日,天茂集团总股本为4904139165股,控股股东新理益集团、实控人刘益谦及一致 行动人王薇合计持有天茂集团66.78%股份,刚刚达到三分之二的门槛;而另外持股33.23%的其他股东 将对议案表决通过与否起着关键作用。 天茂集团此次设置了投资者保护机制安排。公告显示,本次终止上市事项经股东会审议通过后,由荆门 市维拓宏程管理合伙企业(有限合伙)向除新理益集团、王薇、刘益谦外现金选择权股权登记日登记在册 的全体A股股东提供现金选择权(限售或存在权利限制的股份等情形除外)。行使现金选择权的天茂集团 股东可就其有效申报的每一股天茂集团股份,在现金选择权实施日获得由相关现金选择权提供方按现金 选择权价格支付的现金对价,同时将相对应的股份过户至相关现金选择权提供方名下。 A股又有一家上市公司拟主动退市。 近日,天茂实业集团股份有限公司(以下简称"天茂集团")发布公告称,公司拟以股东会决议方式主动撤 回A股股票在深交所的上市交易。不过,目前以股东会决议方式主动退市尚须股东表决通过。 值得关注的是,在此次主动申请退市前,因2024年年报难产,天茂集团本身也面临着较大的退市压力。 今年以来,A股已有多家 ...